Ligand validation:6JXI

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6JXI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JXI_NAG_B_301	72%	74%	0.127	0.953	0.53	0.48	-	-	1	0	100%	0.9333
6JXI_NAG_B_302	49%	66%	0.149	0.896	0.41	0.86	-	1	0	0	100%	0.9333
6JXI_NAG_B_306	26%	55%	0.233	0.873	1.03	0.72	1	-	0	0	100%	0.9333
6JXI_NAG_B_307	8%	73%	0.393	0.876	0.65	0.39	-	-	1	0	100%	0.9333
6JXI_NAG_B_305	1%	90%	0.583	0.745	0.23	0.39	-	-	0	0	100%	0.9333
5YLV_NAG_B_301	67%	61%	0.151	0.962	0.56	0.92	-	1	0	0	100%	0.9333
7W47_NAG_B_301	64%	55%	0.151	0.952	0.57	1.16	1	2	1	0	100%	0.9333
7EFM_NAG_B_301	63%	48%	0.15	0.946	1	1	2	1	0	0	100%	0.9333
6JXH_NAG_B_303	62%	70%	0.15	0.944	0.61	0.54	-	-	1	0	100%	0.9333
7W49_NAG_B_301	60%	80%	0.174	0.961	0.25	0.58	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.